Clifford Swan Investment Counsel LLC / BMY
Clifford Swan Investment Counsel LLC’s Bristol-Myers Squibb Co Position
Does Clifford Swan Investment Counsel LLC own Bristol-Myers Squibb Co (BMY)? Yes — 301.5K shares worth $18M (+0.62% of its 13F portfolio) as of Q1 2026, down from 309.5K shares the prior filed quarter.
Position Value
$18M
Q1 2026
Shares
301.5K
% of Portfolio
+0.62%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 301.5K | $18M | +0.62% |
| Q4 2025 | 309.5K | $17M | +0.55% |
| Q3 2025 | 326.0K | $15M | +0.49% |
| Q2 2025 | 348.0K | $16M | +0.57% |
| Q1 2025 | 400.8K | $24M | +0.90% |
| Q4 2024 | 427.0K | $24M | +0.87% |
| Q3 2024 | 457.1K | $24M | +0.84% |
| Q2 2024 | 405.6K | $17M | +0.63% |
| Q1 2024 | 421.1K | $23M | +0.85% |
| Q4 2023 | 423.8K | $22M | +0.85% |
| Q3 2023 | 438.7K | $25M | +1.07% |
| Q2 2023 | 441.0K | $28M | +1.14% |
| Q1 2023 | 444.9K | $31M | +1.29% |
| Q4 2022 | 447.5K | $32M | +1.40% |
| Q3 2022 | 469.6K | $33M | +1.57% |
| Q2 2022 | 494.9K | $38M | +1.65% |
| Q1 2022 | 505.2K | $37M | +1.37% |
| Q4 2021 | 525.5K | $33M | +1.15% |
| Q3 2021 | 525.1K | $31M | +1.13% |
| Q2 2021 | 521.1K | $36M | +1.35% |
| Q1 2021 | 521.1K | $33M | +1.35% |
| Q4 2020 | 520.2K | $32M | +1.41% |
| Q3 2020 | 534.3K | $32M | +1.54% |
| Q2 2020 | 534.4K | $31M | +1.62% |
| Q1 2020 | 539.1K | $30M | +1.83% |
| Q4 2019 | 540.8K | $35M | +1.68% |
| Q3 2019 | 537.7K | $27M | +1.42% |
| Q2 2019 | 524.2K | $24M | +1.25% |
| Q1 2019 | 485.0K | $23M | +1.24% |
| Q4 2018 | 456.2K | $24M | +1.44% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Clifford Swan Investment Counsel LLC’s full portfolio or all institutional holders of BMY.